Nearly 300 non-invasive diagnostic tests, designed for the detection

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.
 
To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this link 
The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across the following segments:
Type of Tumor Marker
  • ctDNA
  • cfDNA
  • CTCs
  • Exosomes
  • Others
Application
  • Diagnosis / Early Diagnosis
  • Patient Monitoring
  • Recurrence Monitoring
Target Cancer Indication
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Bladder Cancer
  • Melanoma
  • Gastric Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

End Users

  • Hospitals
  • Research Institutes
  • Others

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
The Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers report features the following companies, which we identified to be key players in this domain:

Amoy Diagnostics

DiaCarta

HaploX Biotechnology

NeoGenomics

QIAGEN

Swift Biosciences

Sysmex Inostics

Thermo Fisher Scientific

Press Release: Variation 3 (Format 4)

 

Table of Contents

 
1. Preface

2. Executive Summary

3. Introduction
 
4. Non-Invasive Cancer Screening and Diagnosis


 5. Market Landscape
  
 6. Company Profiles 


 7. Partnerships and Collaborations
  
 8. Funding and Investment Analysis


 9. Liquid Biopsy: Initiatives of Big Pharma Players


 10. Key Acquisition Targets
  
 11. Other Non-Invasive Cancer Diagnostics


 12. Market Sizing and Opportunity Analysis


 13. Survey Insights
  
 14. Conclusion


 15. Executive Insights
  
 16. Appendix 1: Tabulated Data
  
 17. Appendix 2: List of Companies and Organizations
  
 To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
  

Contact Details

 

Gaurav Chaudhary

 

+1 (415) 800 3415

 [email protected] 

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
628 Posts

Made with by Mamby